Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Janssen (BetaLogics)

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of transformational stem cell therapy to treat diabetes. The company is developing stem cell-derived therapy for diabetes treatment and to eliminate a need for exogenous insulin.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Acquirer
Primary Office
  • Horsham, PA
  • United States

Janssen (BetaLogics) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Janssen (BetaLogics)‘s full profile, request access.

Request full access to PitchBook

Janssen (BetaLogics) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Janssen (BetaLogics)‘s full profile, request access.

Request full access to PitchBook